Insights into drug discovery from natural products through structural modification

被引:100
作者
Chen, Jichao
Li, Wenlong
Yao, Hequan
Xu, Jinyi
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Dept Med Chem, Nanjing 210009, Peoples R China
关键词
Natural products; Druggability; Structural modification; GAMMA-SECRETASE MODULATORS; HUMAN SERUM-ALBUMIN; POTENT IMMUNOSUPPRESSIVE ACTIVITY; METASTATIC BREAST-CANCER; HALICHONDRIN-B ANALOG; CHEMICAL SPACE; IN-VIVO; COMBRETASTATIN A-4; BIOLOGICAL EVALUATION; ANTIMALARIAL ACTIVITY;
D O I
10.1016/j.fitote.2015.04.012
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Natural products (NPs) have played a key role in drug discovery and are still a prolific source of novel lead compounds or pharmacophores for medicinal chemistry. Pharmacological activity and druggability are two indispensable components advancing NPs from leads to drugs. Although naturally active substances are usually good lead compounds, most of them can hardly satisfy the demands for druggability. Hence, these structural phenotypes have to be modified and optimized to overcome existing deficiencies and shortcomings. This review illustrates druggability optimization of NPs through structural modification with some successful examples. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:231 / 241
页数:11
相关论文
共 145 条
  • [1] Survival benefit of eribulin mesylate in heavily pretreated metastatic breast cancer: What next?
    Aftimos, Philippe
    Awada, Ahmad
    [J]. ADVANCES IN THERAPY, 2011, 28 (11) : 973 - 985
  • [2] Epothilones: A novel class of non-taxane microtubule-stabilizing agents
    Altaha, R
    Fojo, T
    Reed, E
    Abraham, J
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (19) : 1707 - 1712
  • [3] Isocombretastatins A: 1,1-Diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds
    Alvarez, Raquel
    Alvarez, Concepcion
    Mollinedo, Faustino
    Sierra, Beatriz G.
    Medarde, Manuel
    Pelaez, Rafael
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (17) : 6422 - 6431
  • [4] [Anonymous], 2005, PHARMACOPOEIA PEOPLE, VI, P213
  • [5] [Anonymous], 2014, GUIDANCE DETERMINING
  • [6] Novel hybrids of natural isochroman-4-one bearing N-substituted isopropanolamine as potential antihypertensive candidates
    Bai, Renren
    Huang, Xiaojing
    Yang, Xue
    Hong, Wen
    Tang, Yiqun
    Yao, Hequan
    Jiang, Jieyun
    Liu, Jie
    Shen, Mingqin
    Wu, Xiaoming
    Xu, Jinyi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (09) : 2495 - 2502
  • [7] Novel nitric oxide-releasing isochroman-4-one derivatives: Synthesis and evaluation of antihypertensive activity
    Bai, Renren
    Yang, Xue
    Zhu, Yao
    Zhou, Zhiwen
    Xie, Weijia
    Yao, Hequan
    Jiang, Jieyun
    Liu, Jie
    Shen, Mingqin
    Wu, Xiaoming
    Xu, Jinyi
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (23) : 6848 - 6855
  • [8] Homocamptothecins: potent topoisomerase I inhibitors and promising anticancer drugs
    Bailly, C
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2003, 45 (01) : 91 - 108
  • [9] The value of natural products to future pharmaceutical discovery
    Baker, Dwight D.
    Chu, Min
    Oza, Uma
    Rajgarhia, Vineet
    [J]. NATURAL PRODUCT REPORTS, 2007, 24 (06) : 1225 - 1244
  • [10] A diaryl sulfide, sulfoxide, and sulfone bearing structural similarities to combretastatin A-4
    Barbosa, Euzebio G.
    Bega, Luis A. S.
    Beatriz, Adilson
    Sarkar, Taradas
    Hamel, Ernest
    do Amaral, Marcos S.
    de Lima, Denis Pires
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (06) : 2685 - 2688